Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation
Frontiers in Cellular and Infection Microbiology · 06.02.2023 · 13
DOI: 10.3389/fcimb.2023.1098457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.02.2023. Verfasst von Gabriela Venturini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Harvard Medical School, Boston, MA, United States. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Cardiomyopathy, Chagas Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute, NHLBI NIH HHS, British Heart Foundation.
Abstract (Originalsprache)
Introduction
Chagas cardiomyopathy, a disease caused by Trypanosoma cruzi ( T. cruzi ) infection, is a major contributor to heart failure in Latin America. There are significant gaps in our understanding of the mechanism for infection of human cardiomyocytes, the pathways activated during the acute phase of the disease, and the molecular changes that lead to the progression of cardiomyopathy.
Methods
To investigate the effects of T. cruzi on human cardiomyocytes during infection, we infected induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) with the parasite and analyzed cellular, molecular, and metabolic responses at 3 hours, 24 hours, and 48 hours post infection (hpi) using transcriptomics (RNAseq), proteomics (LC-MS), and metabolomics (GC-MS and Seahorse) analyses.
Results
Analyses of multiomic data revealed that cardiomyocyte infection caused a rapid increase in genes and proteins related to activation innate and adaptive immune systems and pathways, including alpha and gamma interferons, HIF-1α signaling, and glycolysis. These responses resemble prototypic responses observed in pathogen-activated immune cells. Infection also caused an activation of glycolysis that was dependent on HIF-1α signaling. Using gene editing and pharmacological inhibitors, we found that T. cruzi uptake was mediated in part by the glucose-facilitated transporter GLUT4 and that the attenuation of glycolysis, HIF-1α activation, or GLUT4 expression decreased T. cruzi infection. In contrast, pre-activation of pro-inflammatory immune responses with LPS resulted in increased infection rates.
Conclusion
These findings suggest that T. cruzi exploits a HIF-1α-dependent, cardiomyocyte-intrinsic stress-response activation of glycolysis to promote intracellular infection and replication. These chronic immuno-metabolic responses by cardiomyocytes promote dysfunction, cell death, and the emergence of cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Harvard Medical School, Boston, MA, United States.
- Laboratory of Genetics and Molecular Cardiology, University of São Paulo Medical School, São Paulo, Brazil.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
- Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
- LizarBio Therapeutics, Sao Paulo, Brazil.
- Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, São Paulo, Brazil.
Förderung
- Howard Hughes Medical Institute
- NHLBI NIH HHS
- British Heart Foundation
- Wellcome Trust
- NICHD NIH HHS
- National Institutes of Health
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Venturini, G., Alvim, J. M., Padilha, K., Toepfer, C. N., Gorham, J. M., Wasson, L. K., Biagi, D., Schenkman, S., Carvalho, V. M., Salgueiro, J. S., Cardozo, K. H. M., Krieger, J. E., Pereira, A. C., Seidman, J. G., & Seidman, C. E. (2023). Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1098457
Vancouver
Venturini G, Alvim JM, Padilha K, Toepfer CN, Gorham JM, Wasson LK, et al. Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1098457
BibTeX
@article{Venturini2023,
author = {Venturini, Gabriela and Alvim, Juliana M and Padilha, Kallyandra and Toepfer, Christopher N and Gorham, Joshua M and Wasson, Lauren K and Biagi, Diogo and Schenkman, Sergio and Carvalho, Valdemir M and Salgueiro, Jessica S and Cardozo, Karina H M and Krieger, Jose E and Pereira, Alexandre C and Seidman, Jonathan G and Seidman, Christine E},
title = {Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1098457}
}
EUVIMED